N
MXCT icon

Nuveen’s MaxCyte MXCT Stock Holding History

Nuveen’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$153K Buy
218,497
+1,186
+0.5% +$1.11K ﹤0.01% 3140
2025
Q4 		$337K Hold
217,311
– – ﹤0.01% 3014
2025
Q3 		$343K Hold
217,311
– – ﹤0.01% 3022
2025
Q2 		$474K Sell
217,311
-51,230
-19% -$124K ﹤0.01% 2901
2025
Q1 		$733K Hold
268,541
– – ﹤0.01% 2767
2024
Q4 		$1.12M Sell
268,541
-102,020
-28% -$386K ﹤0.01% 2665
2024
Q3 		$1.44M Buy
370,561
+102,020
+38% +$430K ﹤0.01% 2588
2024
Q2 		$1.05M Buy
268,541
+20,549
+8% +$88.4K ﹤0.01% 2705
2024
Q1 		$1.04M Hold
247,992
– – ﹤0.01% 2692
2023
Q4 		$1.17M Buy
247,992
+2,337
+1% +$9.1K ﹤0.01% 2669
2023
Q3 		$766K Sell
245,655
-2,964
-1% -$11.9K ﹤0.01% 2684
2023
Q2 		$1.14M Hold
248,619
– – ﹤0.01% 2600
2023
Q1 		$1.23M Sell
248,619
-106,666
-30% -$525K ﹤0.01% 2533
2022
Q4 		$1.94M Sell
355,285
-37,571
-10% -$230K ﹤0.01% 2400
2022
Q3 		$2.55M Sell
392,856
-7,375
-2% -$41.1K ﹤0.01% 2274
2022
Q2 		$1.89M Buy
400,231
+83,860
+27% +$413K ﹤0.01% 2460
2022
Q1 		$2.11M Sell
316,371
-35,017
-10% -$239K ﹤0.01% 2479
2021
Q4 		$3.31M Buy
351,388
+281,156
+400% +$3.02M ﹤0.01% 2324
2021
Q3 		$858K Buy
+70,232
New +$1.06M ﹤0.01% 3044

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

Nuveen's MXCT Position: Q1 2026 in Review

Nuveen increased its MaxCyte (MXCT) stake by 0.55% in Q1 2026, buying an estimated $1.11K and bringing the position to 218,497 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #3140.

Nuveen first reported a position in MXCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.31M in Q4 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Nuveen held 218,497 shares of MaxCyte worth $153K as of Q1 2026.
  • Nuveen bought 1,186 MaxCyte shares in Q1 2026, an estimated $1.11K.
  • MaxCyte made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #3140 holding.
  • Nuveen first reported a position in MaxCyte in Q3 2021 and has held it in 19 quarters since.
  • Nuveen's MaxCyte position peaked at $3.31M in Q4 2021.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.